Reaction
Autoimmune Arthritis reporting signals
As of the last recalculation, Autoimmune Arthritis appears in 153 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is IPILIMUMAB (PRR 107.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ipilimumab | 28 | 107.8 | 107.9 |
| Nivolumab | 37 | 68.4 | 68.4 |
| Pembrolizumab | 37 | 62.8 | 62.8 |